Cision Unveils “Inside PR 2026”: The Definitive Report on PR Trends, AI Adoption, and the Future of Communications

8 hours ago

New research reveals how PR teams are adapting to resource pressures, media fragmentation, and the accelerating shift toward AI and…

MICROIP Highlights AIVO Edge AI Platform at CES 2026, Enabling Scalable Deployment Across Transportation Security, Agriculture, and Autonomous Systems

8 hours ago

LAS VEGAS, Jan. 6, 2026 /PRNewswire/ -- MICROIP Inc., a Taiwan-based provider of ASIC design services and AI software solutions,…

Simplilearn Joins IndiaAI Mission to Accelerate AI Literacy for 10 Million Citizens

11 hours ago

BANGALORE, India, Jan. 6, 2026 /PRNewswire/ -- Simplilearn, a leading global digital upskilling platform, has collaborated with the IndiaAI Mission,…

Pole Star Global launches Maritime Transparency Index — turning 25 years of maritime intelligence into instant vessel and voyage risk verdicts

11 hours ago

LONDON, Jan. 6, 2026 /PRNewswire/ -- Pole Star Global, a world leader in maritime intelligence and regulatory compliance solutions, today announced…

Tomorrowland announces its first-ever Thailand edition, launching as a full-scale festival in December 2026

11 hours ago

BANGKOK and ANTWERP, Belgium, Jan. 6, 2026 /PRNewswire/ -- Thailand is set to become the stage for a brand-new chapter in…

GIGABYTE Unleashes the Full Power of X3D Enabled AMD Ryzen 9000 Series Processors with AI-powered X3D Turbo Mode 2.0 at CES 2026

11 hours ago

TAIPEI, Jan. 6, 2026 /PRNewswire/ -- At CES 2026, GIGABYTE is unlocking the full potential of AMD Ryzen™ 9000 Series…

GIGABYTE Unveils “Refine & Define” Shaping Future of AI Computing at CES 2026

11 hours ago

TAIPEI, Jan. 6, 2026 /PRNewswire/ -- GIGABYTE, the world's leading computer brand, today unveiled its new philosophy, "Refine & Define,"…

Clarivate Identifies Eleven Potential Blockbuster and Transformative Therapies in its 2026 Drugs to Watch Report

11 hours ago

Anticipated advancements in weight loss, diabetes, oncology, rare conditions and protein degraders poised to reshape patient careLONDON, Jan. 6, 2026…

Ark Biopharmaceutical Receives China Marketing Authorization for Azstarys for the Treatment of ADHD

11 hours ago

SHANGHAI, Jan. 6, 2026 /PRNewswire/ -- Shanghai Ark Biopharmaceutical Co., Ltd. ("ArkBio") today announced that China's National Medical Products Administration…

Esco Aster Signs Exosome Clinical cGMP Manufacturing Contract With Shine-On Biomedical For A Novel First-In-Class HLA-G Targeting Exosome Drug Delivery Platform

11 hours ago

SINGAPORE, Jan. 6, 2026 /PRNewswire/ -- Esco Aster, a vertically integrated cell and derivatives CRDMO based at JTC LaunchPad Singapore,…